CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus

Fernando Ferrero, Chien-Yu Lin, Johannes Liese, Kleber Luz, Tatyana Stoeva, Agnes Nemeth, Manuel Gijón, Cristina Calvo, Silvina Natalini, Teck-Hock Toh, Sofie Deleu, Bohang Chen, Sarah Rusch, Beatriz López Sánchez, Illse Leipoldt, Leen Vijgen, Dymphy Huntjens, Tristan Baguet, Kristi Bertzos, Mohamed Gamil, Marita Stevens, Unknown

Open source

DOI: 10.1007/s40272-024-00625-x
Published: 2024-04-22
Container: Pediatric Drugs
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40272-024-00625-x,
  title = {CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus},
  author = {Fernando Ferrero and Chien-Yu Lin and Johannes Liese and Kleber Luz and Tatyana Stoeva and Agnes Nemeth and Manuel Gijón and Cristina Calvo and Silvina Natalini and Teck-Hock Toh and Sofie Deleu and Bohang Chen and Sarah Rusch and Beatriz López Sánchez and Illse Leipoldt and Leen Vijgen and Dymphy Huntjens and Tristan Baguet and Kristi Bertzos and Mohamed Gamil and Marita Stevens and Unknown},
  year = {2024},
  journal = {Pediatric Drugs},
  doi = {10.1007/s40272-024-00625-x},
  url = {https://doi.org/10.1007/s40272-024-00625-x}
}

RIS

TY  - JOUR
TI  - CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus
AU  - Fernando Ferrero
AU  - Chien-Yu Lin
AU  - Johannes Liese
AU  - Kleber Luz
AU  - Tatyana Stoeva
AU  - Agnes Nemeth
AU  - Manuel Gijón
AU  - Cristina Calvo
AU  - Silvina Natalini
AU  - Teck-Hock Toh
AU  - Sofie Deleu
AU  - Bohang Chen
AU  - Sarah Rusch
AU  - Beatriz López Sánchez
AU  - Illse Leipoldt
AU  - Leen Vijgen
AU  - Dymphy Huntjens
AU  - Tristan Baguet
AU  - Kristi Bertzos
AU  - Mohamed Gamil
AU  - Marita Stevens
AU  - Unknown
PY  - 2024
JO  - Pediatric Drugs
DO  - 10.1007/s40272-024-00625-x
UR  - https://doi.org/10.1007/s40272-024-00625-x
ER  -

APA

Ferrero, F., Lin, C., Liese, J., Luz, K., Stoeva, T., Nemeth, A., Gijón, M., Calvo, C., Natalini, S., Toh, T., Deleu, S., Chen, B., Rusch, S., Sánchez, B. L., Leipoldt, I., Vijgen, L., Huntjens, D., Baguet, T., Bertzos, K., Gamil, M., Stevens, M., & Unknown (2024). CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus. Pediatric Drugs. https://doi.org/10.1007/s40272-024-00625-x

Source records

crossref · retrieved 2026-09-25T03:32:17.442Z